Alliance Pharma Plc Announces the Termination of Martin Sutherland as Director, Effective May 14, 2025

Published on 13/05/2025 at 23:00

S&P Capital IQ

Alliance Pharma Plc announced the termination of Mr. Martin Sutherland as Director. Date of termination: May 14, 2025.

Latest news about Alliance Pharma plc

Alliance Pharma Delists from London Bourse's AIM After Acquisition	05-15	MT
Aegros Bidco Completes Takeover of Alliance Pharma	05-14	MT
Alliance Pharma Says Aegros Bidco Recommends Acquisition Of Alliance Pharma	05-14	RE
Alliance Pharma plc Announces the Termination of Camillo Pane as Director, Effective May 14, 2025	05-13	CI
Alliance Pharma plc Announces the Termination of Mr. Richard Alexander Mckenzie as Director, Effective from May 14, 2025	05-13	CI
Alliance Pharma Plc Announces the Termination of Martin Sutherland as Director, Effective May 14, 2025	05-13	CI
Alliance Pharma plc Announces the Termination of Kristof Leon Neirynck as Director, Effective from May 14, 2025	05-13	CI
Alliance Pharma plc Announces the Termination of Richard Crispin Jones as Director, Effective from May 14, 2025	05-13	CI
Alliance Pharma Plc Announces the Termination of Eva-Lotta Saga Sjostedt as Director, Effective May 14, 2025	05-13	CI
An undisclosed funds, managed by DBAY Advisors Limited, An undisclosed funds, managed by Baring Asset Management Limited, Edmond De Rothschild Equity Strategies IV Fund, a fund managed by Edmond de Rothschild Private Equity Management Ltd. and an undisclosed buyer completed the acquisition of remaining 71.9% stake in Alliance Pharma plc from Andrew Franklin, Richard Jones, Nick Sedgwick, Slater Investments Limited and others.	05-13	CI
Aegros' Takeover of Alliance Pharma Sanctioned by Court	05-13	MT
Slater Investments Discloses 4.37% Stake In Alliance Pharma As Of 25-Apr-2025	04-29	RE
Alliance Pharma loss narrows in 2024 due to reduced impairment charges	04-08	AN
Alliance Pharma Says Group Performance In Three Months To End March In-Line With Expectations	04-08	RE
Alliance Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2024	04-08	CI
Alliance Pharma-Aegros Bidco Deal Secures Regulatory Clearances	03-21	MT
Aegros Bidco's Bid Gets Alliance Pharma Shareholders' Nod	03-13	MT
PRESS DIGEST-British Business - March 11	03-11	RE
Deals of the day-Mergers and acquisitions	03-10	RE
Alliance Pharma board backs final GBP362 million takeover bid	03-10	AN
Alliance Pharma Receives Final Increased Takeover Offer from Aegros Bidco	03-10	MT
Deals of the day-Mergers and acquisitions	03-10	RE
UK's Alliance Pharma accepts DBAY's sweetened final offer	03-10	RE
Alliance Pharma Agrees To Final Cash Offer From DBAY	03-10	RE
UK's Alliance Pharma agrees to final cash offer from asset management firm DBAY	03-10	RE

ALLIANCE PHARMA PLC

Stock

APH

GB0031030819

Chart

Duration

Period

APH: Dynamic Chart

Headlines

Weekly market update: Earnings Wave Ahead

Ashish Kacholia and Dolly Khanna: India's Star Investors Send Portfolio Signals

July 18, 2025 at 10:13 am

Employment figures offer some respite for the Bank of England

July 17, 2025 at 03:25 pm

Results preview: Legrand accelerates

July 17, 2025 at 10:51 am

Crypto companies face the fatal trap of Bitcoin - Crypto roundup

July 17, 2025 at 10:24 am

When volatility boosts US banks

July 17, 2025 at 09:42 am

Shorting the dollar: the most popular trade amongst fund managers

July 17, 2025 at 08:20 am

Perplexity in talks with phone makers to pre-install Comet AI mobile browser on devices

July 18, 2025 at 11:44 pm

Union Pacific, Norfolk Southern explore cross-continental railroad merger, source says

July 18, 2025 at 10:46 pm

AI models with systemic risks given pointers on how to comply with EU AI rules

July 18, 2025 at 10:19 pm

All our articles